Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Clements

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|May 1, 1990
Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteersM L Clements, M H Snyder, S D Sears, et al.
Journal of the American Geriatrics Society|February 1, 1992
Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodiesD C Powers, B R Murphy, L F Fries, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsR A Karron, M Makhene, K Gay, et al.
The Journal of Infectious Diseases|October 1, 1983
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials NetworkM C Keefer, R Belshe, B Graham, et al.
Recombinant DNA Technical Bulletin|September 1, 1983
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccinesT A Brown, M L Clements, B R Murphy, et al.
JAMA|August 11, 1989
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineP G Miotti, K E Nelson, G A Dallabetta, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials NetworkR Viscidi, E Ellerbeck, L Garrison, et al.
The Journal of Infectious Diseases|October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccinesS Zolla-Pazner, S Xu, S Burda, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|May 1, 1990
Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteersM L Clements, M H Snyder, S D Sears, et al.
Journal of the American Geriatrics Society|February 1, 1992
Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodiesD C Powers, B R Murphy, L F Fries, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsR A Karron, M Makhene, K Gay, et al.
The Journal of Infectious Diseases|October 1, 1983
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials NetworkM C Keefer, R Belshe, B Graham, et al.
Recombinant DNA Technical Bulletin|September 1, 1983
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccinesT A Brown, M L Clements, B R Murphy, et al.
JAMA|August 11, 1989
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineP G Miotti, K E Nelson, G A Dallabetta, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials NetworkR Viscidi, E Ellerbeck, L Garrison, et al.
The Journal of Infectious Diseases|October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccinesS Zolla-Pazner, S Xu, S Burda, et al.
Pageof 13